News | January 29, 2024
Jubilant Pharmova Singapore to sell its entire 25.8% stake in Sofie Biosciences, USA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in a 52-week clinical trial
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Acquisition delivers industry-leading research capability, and strengthens pipeline with a novel candidate for ulcerative colitis, Crohn’s disease and other autoimmune conditions
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Yinjia Biosciences will provide Porton Advanced with high-quality core protein raw materials and testing reagent products for quality control and evaluation systems.
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
The company has reported total income of Rs. 79.33 crores during the period ended December 31, 2022
Subscribe To Our Newsletter & Stay Updated
